ATE206110T1 - Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen - Google Patents

Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE206110T1
ATE206110T1 AT96917304T AT96917304T ATE206110T1 AT E206110 T1 ATE206110 T1 AT E206110T1 AT 96917304 T AT96917304 T AT 96917304T AT 96917304 T AT96917304 T AT 96917304T AT E206110 T1 ATE206110 T1 AT E206110T1
Authority
AT
Austria
Prior art keywords
semicarbazones
cns
active
pharmaceutical preparations
preparations containing
Prior art date
Application number
AT96917304T
Other languages
English (en)
Inventor
Jonathan Richard Dimmock
Ramanan Narayan Puthucode
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23887035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE206110(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE206110T1 publication Critical patent/ATE206110T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/14Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96917304T 1995-06-07 1996-06-07 Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen ATE206110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,313 US5741818A (en) 1995-06-07 1995-06-07 Semicarbazones having CNS activity and pharmaceutical preparations containing same
PCT/CA1996/000380 WO1996040628A1 (en) 1995-06-07 1996-06-07 Semicarbazones having cns activity and pharmaceutical preparations containing same

Publications (1)

Publication Number Publication Date
ATE206110T1 true ATE206110T1 (de) 2001-10-15

Family

ID=23887035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917304T ATE206110T1 (de) 1995-06-07 1996-06-07 Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen

Country Status (24)

Country Link
US (2) US5741818A (de)
EP (1) EP0836591B1 (de)
JP (1) JPH11506109A (de)
KR (1) KR19990022408A (de)
CN (1) CN1062263C (de)
AT (1) ATE206110T1 (de)
AU (1) AU715897B2 (de)
BR (1) BR9609408A (de)
CA (1) CA2223935A1 (de)
CZ (1) CZ387497A3 (de)
DE (1) DE69615558T2 (de)
DK (1) DK0836591T3 (de)
ES (1) ES2164889T3 (de)
FI (1) FI974447A7 (de)
GE (1) GEP20012414B (de)
HU (1) HUP9802637A3 (de)
IL (1) IL122350A0 (de)
NO (1) NO310655B1 (de)
NZ (1) NZ309707A (de)
PL (1) PL184048B1 (de)
PT (1) PT836591E (de)
RU (1) RU2174115C2 (de)
UA (1) UA62915C2 (de)
WO (1) WO1996040628A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
WO1998047869A1 (en) * 1997-04-22 1998-10-29 Cocensys, Inc. Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
EP1568690A1 (de) * 1997-04-22 2005-08-31 Euro-Celtique S.A. Durch carbozyklische und heterozyklische substituierte Semicarbazone und Thiosemicarbazone und ihre Anwendung als Natriumkanalblocker
ES2402104T3 (es) 1997-11-21 2013-04-29 Purdue Neuroscience Company Uso de 2-aminoacetamidas sustituidas para el tratamiento o alivio de la ansiedad
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
IL137671A0 (en) * 1998-02-04 2001-10-31 Euro Celtique Sa Semicarbazide derivatives and pharmaceutical compositions containing the same
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
JP4832647B2 (ja) 1999-03-26 2011-12-07 ユーロ−セルティック エス. ア. アリール置換ピラゾール、イミダゾール、オキサゾール、チアゾールおよびピロール、ならびにそれらの使用
CA2370030C (en) * 1999-04-09 2007-08-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
WO2001045674A1 (en) 1999-12-20 2001-06-28 Cocensys, Inc. Process for producing nanometer particles by fluid bed spray-drying
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
HK1056164B (en) * 2000-03-24 2013-06-21 Euro-Celtique S.A. Aryl-substituted pyrazole, triazole and tetrazole, and their uses
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
AU2002303694A1 (en) * 2001-05-10 2002-11-18 Sui Xiong Cai Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2002098420A1 (en) * 2001-06-01 2002-12-12 Cytovia, Inc. 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
DK1423168T3 (da) 2001-09-03 2006-05-15 Newron Pharm Spa Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
CA2484702A1 (en) * 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7476741B2 (en) * 2002-05-16 2009-01-13 Cytovia, Inc. Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1438956A1 (de) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-Aminoamidderivate die als Antimigränemittel nützlich sind
US20080096965A1 (en) * 2004-09-10 2008-04-24 Newron Pharmaceuticals S.P.A. (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
EP2532643A1 (de) 2007-06-08 2012-12-12 MannKind Corporation IRE-1a-Inhibitoren
EP2387481B1 (de) * 2008-12-10 2018-03-14 Boston Scientific Scimed, Inc. Verfahren zum verbinden von titanlegierung und stahllegierung und medizinisches bauteil mit einer solchen verbindung
CN104402771B (zh) * 2014-11-26 2016-09-28 玉林师范学院 对羟基苯甲醛缩氨基脲的合成及在防治植物病害中的应用
CN104974053B (zh) * 2015-06-24 2017-04-26 天津久日新材料股份有限公司 一种新的氨基酮类光引发剂及在uv‑led光固化体系的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667022A (de)
NL273765A (de) 1961-01-19
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
BE622079A (de) 1961-09-11
US3251064A (en) 1962-11-13 1966-05-10 Everett M Schultz beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids
NL300456A (de) 1962-11-13
BE643709A (de) * 1963-02-12 1900-01-01
DE1288086B (de) * 1963-12-26 1969-01-30
US3392171A (en) * 1964-03-20 1968-07-09 Upjohn Co 4-morpholino-4'-hydroxy bicyclohexyls
US3304323A (en) * 1964-03-20 1967-02-14 Upjohn Co Oxygenated dicycloalkyl sulfones
US3303214A (en) * 1964-05-13 1967-02-07 Wallace & Tiernan Inc Nitrososemicarbazides
GB1164608A (en) * 1966-08-23 1969-09-17 May & Baker Ltd Semicarbazone and Thiosemicarbazone Quaternary Salts
US3712914A (en) * 1970-05-14 1973-01-23 Stauffer Chemical Co Arylidene semicarbizides
DE2420618C2 (de) * 1974-04-27 1982-09-16 C.H. Boehringer Sohn, 6507 Ingelheim Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten
US4394514A (en) * 1981-04-30 1983-07-19 Smithkline Beckman Corporation Processes for preparing 4-substituted indoles
FI77458C (fi) * 1981-05-12 1989-03-10 Ciba Geigy Ag Nya mikrobicida arylfenyleterderivat, foerfarande foer deras framstaellning och deras anvaendning.
US5266585A (en) 1981-05-12 1993-11-30 Ciba-Geigy Corporation Arylphenyl ether derivatives, compositions containing these compounds and use thereof
US4454337A (en) * 1981-06-29 1984-06-12 Smithkline Beckman Corporation Semicarbazide intermediates for preparing 4-substituted indoles
US5665673A (en) 1988-12-29 1997-09-09 Anderson; Richard J. Potentiating herbicidal compositions
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
WO1994006758A1 (en) * 1992-09-21 1994-03-31 University Of Saskatchewan Aryl semicarbazone anticonvulsants
JPH10503171A (ja) 1994-05-17 1998-03-24 ダウエランコ N−(5−イソチアゾリル)アミド有害生物防除剤
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
CZ132798A3 (cs) 1995-10-30 1999-02-17 Smithkline Beecham Corporation Inhibitory proteázy

Also Published As

Publication number Publication date
CA2223935A1 (en) 1996-12-19
RU2174115C2 (ru) 2001-09-27
FI974447L (fi) 1997-12-05
HUP9802637A2 (hu) 1999-02-01
NZ309707A (en) 1998-11-25
KR19990022408A (ko) 1999-03-25
ES2164889T3 (es) 2002-03-01
UA62915C2 (en) 2004-01-15
NO310655B1 (no) 2001-08-06
FI974447A0 (fi) 1997-12-05
HUP9802637A3 (en) 2000-09-28
PL323666A1 (en) 1998-04-14
IL122350A0 (en) 1998-04-05
CZ387497A3 (cs) 1998-07-15
FI974447A7 (fi) 1997-12-05
USRE38425E1 (en) 2004-02-10
NO975663L (no) 1998-02-09
GEP20012414B (en) 2001-04-25
EP0836591A1 (de) 1998-04-22
JPH11506109A (ja) 1999-06-02
AU5993896A (en) 1996-12-30
WO1996040628A1 (en) 1996-12-19
CN1190388A (zh) 1998-08-12
PT836591E (pt) 2002-03-28
BR9609408A (pt) 1999-07-27
DE69615558T2 (de) 2002-07-11
NO975663D0 (no) 1997-12-05
AU715897B2 (en) 2000-02-10
DK0836591T3 (da) 2001-11-26
US5741818A (en) 1998-04-21
EP0836591B1 (de) 2001-09-26
DE69615558D1 (de) 2001-10-31
CN1062263C (zh) 2001-02-21
PL184048B1 (pl) 2002-08-30

Similar Documents

Publication Publication Date Title
ATE206110T1 (de) Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen
ATE209186T1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
ATE176664T1 (de) 2-propylvaleriansäure und 2-propylvalerian- säureamid-derivate und deren verwendung als antikonvulsive mittel
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69610628D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ATE168991T1 (de) Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ATE270667T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE152442T1 (de) Substituierte arylalkylaminobenzyl- aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
NZ333869A (en) Alpha-amino acid amides and their use in the treatment of neurodegenerative diseases
ES2092206T3 (es) Medicamentos que contienen un compuesto de imidazol-1-ilo.
DE69825980D1 (de) 4,5-dihydroxy-2-cyclopentene-1-on für die behandlung von rheumatismus, entzündungen und autoimmunerkrankungen
ATE112256T1 (de) 9-amino-2-phenylbicyclo(3.3.1&gt;nonane und 9-amino- 2-phenylbicyclo(3.3.1&gt;-non-2-ene und diese enthaltende therapeutische mittel.
TH17047A (th) อนุพันธ์ของ n-ซับสทิทิวเทด อะซาไบไซโคลเฮพเทน, การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee